MTVA
Price
$0.66
Change
-$0.05 (-7.04%)
Updated
Nov 13 closing price
Capitalization
16.27M
Intraday BUY SELL Signals
SPRB
Price
$112.57
Change
+$10.38 (+10.16%)
Updated
Nov 13 closing price
Capitalization
120.38M
Intraday BUY SELL Signals
Interact to see
Advertisement

MTVA vs SPRB

Header iconMTVA vs SPRB Comparison
Open Charts MTVA vs SPRBBanner chart's image
MetaVia
Price$0.66
Change-$0.05 (-7.04%)
Volume$453.61K
Capitalization16.27M
Spruce Biosciences
Price$112.57
Change+$10.38 (+10.16%)
Volume$272.58K
Capitalization120.38M
MTVA vs SPRB Comparison Chart in %
MTVA
Daily Signal:
Gain/Loss:
SPRB
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
MTVA vs. SPRB commentary
Nov 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MTVA is a Hold and SPRB is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 14, 2025
Stock price -- (MTVA: $0.66 vs. SPRB: $112.57)
Brand notoriety: MTVA and SPRB are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MTVA: 13% vs. SPRB: 40%
Market capitalization -- MTVA: $16.27M vs. SPRB: $120.38M
MTVA [@Biotechnology] is valued at $16.27M. SPRB’s [@Biotechnology] market capitalization is $120.38M. The market cap for tickers in the [@Biotechnology] industry ranges from $110.25B to $0. The average market capitalization across the [@Biotechnology] industry is $2.11B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MTVA’s FA Score shows that 1 FA rating(s) are green whileSPRB’s FA Score has 0 green FA rating(s).

  • MTVA’s FA Score: 1 green, 4 red.
  • SPRB’s FA Score: 0 green, 5 red.
According to our system of comparison, MTVA is a better buy in the long-term than SPRB.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MTVA’s TA Score shows that 4 TA indicator(s) are bullish while SPRB’s TA Score has 3 bullish TA indicator(s).

  • MTVA’s TA Score: 4 bullish, 4 bearish.
  • SPRB’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, MTVA is a better buy in the short-term than SPRB.

Price Growth

MTVA (@Biotechnology) experienced а -22.35% price change this week, while SPRB (@Biotechnology) price change was -5.63% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.47%. For the same industry, the average monthly price growth was -3.12%, and the average quarterly price growth was +62.00%.

Industries' Descriptions

@Biotechnology (+1.47% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SPRB($120M) has a higher market cap than MTVA($16.3M). SPRB YTD gains are higher at: 224.429 vs. MTVA (-65.202). MTVA has higher annual earnings (EBITDA): -20.01M vs. SPRB (-48.11M). SPRB has higher revenues than MTVA: SPRB (1.3M) vs MTVA (0).
MTVASPRBMTVA / SPRB
Capitalization16.3M120M14%
EBITDA-20.01M-48.11M42%
Gain YTD-65.202224.429-29%
P/E RatioN/AN/A-
Revenue01.3M-
Total Cash17.6MN/A-
Total Debt98KN/A-
FUNDAMENTALS RATINGS
MTVA: Fundamental Ratings
MTVA
OUTLOOK RATING
1..100
78
VALUATION
overvalued / fair valued / undervalued
1..100
24
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
64
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
MTVASPRB
RSI
ODDS (%)
Bullish Trend 3 days ago
88%
Bearish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
86%
Bullish Trend 3 days ago
71%
Momentum
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
89%
MACD
ODDS (%)
N/A
Bearish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
89%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
89%
Advances
ODDS (%)
Bullish Trend 11 days ago
81%
Bullish Trend 10 days ago
77%
Declines
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
89%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
90%
N/A
Aroon
ODDS (%)
N/A
N/A
View a ticker or compare two or three
Interact to see
Advertisement
MTVA
Daily Signal:
Gain/Loss:
SPRB
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CUPR0.750.02
+2.71%
Cuprina Holdings (Cayman) Limited
CNO41.640.65
+1.59%
CNO Financial Group
PCG16.810.22
+1.33%
PG&E Corp
ESCA12.670.13
+1.04%
Escalade
AMAL27.89-0.53
-1.86%
Amalgamated Financial Corp

MTVA and

Correlation & Price change

A.I.dvisor indicates that over the last year, MTVA has been loosely correlated with PMVP. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if MTVA jumps, then PMVP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MTVA
1D Price
Change %
MTVA100%
-7.91%
PMVP - MTVA
35%
Loosely correlated
+6.77%
SPRB - MTVA
34%
Loosely correlated
-9.29%
KPRX - MTVA
30%
Poorly correlated
+0.66%
GLUE - MTVA
29%
Poorly correlated
-1.12%
IMTX - MTVA
28%
Poorly correlated
+16.10%
More

SPRB and

Correlation & Price change

A.I.dvisor indicates that over the last year, SPRB has been loosely correlated with NEVPF. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if SPRB jumps, then NEVPF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SPRB
1D Price
Change %
SPRB100%
-9.29%
NEVPF - SPRB
61%
Loosely correlated
N/A
IMRX - SPRB
52%
Loosely correlated
-1.78%
MLEC - SPRB
51%
Loosely correlated
-3.30%
GNFT - SPRB
39%
Loosely correlated
+6.77%
IMCR - SPRB
37%
Loosely correlated
+0.26%
More